Article Details

Eisai announces move to solo development and commercialization of farletuzumab ...

Retrieved on: 2024-07-01 14:37:11

Tags for this article:

Click the tags to see associated articles and topics

Eisai announces move to solo development and commercialization of farletuzumab .... View article details on hiswai:

Excerpt

... antibody drug conjugate (ADC) and that is composed of Eisai's in-house developed farletuzumab, a humanized IgG1 monoclonal antibody that binds to ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up